Hot penny stocks... don't get burned
Research Report
Mary Fisher is a Chief Operating Officer of Acorda Therapeutics. Hotstocked.com has a complete research report available for ACOR stock. Download ACOR report.
Research Report
Get the full report for FREE
Date:Sep 2, 2008
Price:Free
Pages:4
Document Type:Adobe Acrobat Reader
 Download ACOR report
  
Example preview: Research report for Acorda Therapeutics (ACOR) Research report for Acorda Therapeutics (ACOR) Research report for Acorda Therapeutics (ACOR) Research report for Acorda Therapeutics (ACOR)
   

Mary Fisher

Rate this Executive:
Not rated yet Not rated yet.
This is a page dedicated to get more information for investors to evaluate the management style of Mary Fisher who is a Chief Operating Officer of Acorda Therapeutics.

Here on this page we are inviting all readers to discuss Mary Fisher. You may anonymously post comments with any information that they have about Mary Fisher. You can post comments about their management style or whatever you want to talk about concerning their ability as an executive. Please refrain from personal attacks.

User comments


Type the characters that you see in the box (5 characters).

This is a captcha-picture. It is used to prevent mass-access by robots. (see: www.captcha.net)

  

I would like to be notified by e-mail if someone comments on this page. Email confirmation needed. Privacy Statement.
   
   
   
   
Here is a copy of personal Bio that we found:
Name: Mary Fisher
Age: 47
Mary Fisher has been our Chief Operating Officer since January 2005 and previously served as our Vice President, Commercial Operations from 2003 through 2004 and Vice President, Marketing and Strategic Planning from 2000 to 2003. From 1999 to 2000, Ms. Fisher was an independent consultant to various pharmaceutical companies. From 1994 to 1999, Ms. Fisher was Vice President, Strategic Healthcare and Commercial Operations for Cephalon, Inc. In that capacity she was responsible for the company’s corporate sales, managed care marketing, pricing, reimbursement, health economics, patient support programs, product planning, commercial manufacturing, distribution and customer service. From 1990 until joining Cephalon, Ms. Fisher was Corporate Communications Manager for Immunex Corporation.
« Michael P. Cifone Michael Chibib »
   
   
Company name Officer position Pay Exercised
Acorda Therapeutics Chief Operating Officer $ 225.00K $ 0
   
 
Home > Officers > Mary Fisher